ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVXL Anavex Life Sciences Corporation

4.17
-0.33 (-7.33%)
After Hours
Last Updated: 09:04:25
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Anavex Life Sciences Corporation AVXL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.33 -7.33% 4.17 09:04:25
Open Price Low Price High Price Close Price Previous Close
4.50 4.105 4.51 4.17 4.50
more quote information »

Recent News

Date Time Source Heading
22/5/202421:30GLOBEAnavex Life Sciences Announces Expansion of Leadership Team
17/5/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202421:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 2nd..
10/5/202419:45PRNUSShareholders that lost money on Anavex Life Sciences..
10/5/202406:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:00EDGAR2Form 8-K - Current report
09/5/202421:30GLOBEAnavex Life Sciences Reports Fiscal 2024 Second Quarter..
07/5/202419:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
06/5/202420:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/5/202419:45PRNUSAnavex Life Sciences Corporation Sued for Securities Law..
02/5/202421:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 Second Quarter..
26/4/202419:45PRNUSMay 13, 2024 Deadline: Contact The Gross Law Firm to Join..
19/4/202419:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
16/4/202419:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/4/202419:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
11/4/202421:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
09/4/202419:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
05/4/202420:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
02/4/202420:45PRNUSShareholders that lost money on Anavex Life Sciences..
29/3/202420:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
26/3/202420:45PRNUSInvestors who lost money on Anavex Life Sciences..
25/3/202422:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
22/3/202420:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
18/3/202422:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
26/2/202423:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
23/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202408:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202423:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
01/2/202423:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
26/1/202409:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202423:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
16/1/202423:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
13/1/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
03/1/202423:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
03/1/202400:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
20/12/202323:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
19/12/202323:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
28/11/202308:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/11/202300:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
27/11/202322:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
25/11/202300:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
23/11/202300:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
21/11/202300:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
07/11/202300:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
25/10/202323:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..